Magnetolith - Extracorporeal Magnetotransduction EMTT for Advanced Musculoskeletal Treatment

A non-invasive therapy designed to support treatment outcomes in chronic pain, degeneration and complex MSK conditions.
 

EMTT relies on a different operating mechanism to ESWT. Whereas Shockwave acts using high-energy acoustic/physical signals in a local treatment area, EMTT acts using high-energy electromagnetic radiation in a regional treatment area.

Advantages of EMTT

  • Non-invasive, outpatient therapy – with almost no side effects
  • Used in physiotherapy & sports medicine
  • Complements shockwave therapy
  • Treats large areas quickly
  • Wide range of therapies
  • High level of patient comfort and easy to use

 

 

Why add EMTT to your clinic?

Extracorporeal Magnetotransduction Therapy (EMTT) expands treatment capability for clinics managing chronic and complex musculoskeletal conditions.

 

  • Treat broader anatomical regions compared to localised therapies
  • Address chronic and degenerative conditions more effectively
  • Expand your service offering beyond traditional modalities
  • Reduce clinician fatigue with touch-free application
  • Deliver efficient treatments within standard consult times

 

Clinical Applications

Chronic Pain

  • Low back pain
  • Radiculopathy
  • Persistent musculoskeletal pain

 

Degenerative Conditions

  • Osteoarthritis (knee, hip, shoulder, hands)
  • Spondylarthrosis

 

Tendinopathies & Overuse

  • Achilles tendinopathy
  • Rotator cuff
  • Pubic bone inflammation

 

Sports Injuries

  • Chronic inflammation
  • Overload syndromes
  • Soft tissue injury

 

EMTT – New Possibilities in Therapy and Rehabilitation

Application areas of Extracorporeal Magnetotransduction Therapy (EMTT) include diseases of the musculoskeletal system such as pain in the lower back, arthrosis as well as inflammation in tendons and joints. EMTT differs from other general forms of magnetic field therapy or PEMF in its higher oscillation frequency and magnetic field strength, resulting in a strong, effective transduction power. It can be assumed that the faster the magnetic field pulses or the higher the effective transduction power, the more pronounced the bioelectrical activity in the organism will be. These properties also allow the EMTT to reach a large penetration depth (18 cm) and to cover a wide range of applications.

EMTT Operating Principle

EMTT treatment can cause positive biological effects. Every cell undergoes chemical reactions that drive metabolism. The prerequisite for this is membrane permeability. A stable cell membrane ensures permeability for vital substances. A pathological change leads to dysfunction – a metabolic disorder that can ultimately lead to disease. The chemical reactions of the cell potential can be positively influenced by EMTT. The sodium-potassium pump can be reactivated and physiological cell processes can be normalised.

Frequently Asked Questions

What is EMTT therapy?

EMTT is a non-invasive treatment that uses high-energy magnetic pulses to support recovery in musculoskeletal conditions.

 

How is EMTT different to shockwave therapy?

EMTT treats larger regions using electromagnetic energy, while shockwave therapy targets specific areas using acoustic waves.

What conditions can EMTT be used for?

EMTT is commonly used for chronic pain, osteoarthritis, tendinopathy and sports-related injuries.

 

How long does a treatment take with EMTT?

A typical EMTT session lasts between 5 and 20 minutes depending on the condition and treatment protocol.

 

Can EMTT be combined with other therapies?

Yes, EMTT is often used alongside shockwave therapy and other rehabilitation approaches.

Evidence of the significant therapeutic effects of using EMTT devices

  1. Krath, A. et al., J Orthop. 2017;14(3):410-415. doi: 10.1016/j.jor.2017.06.016
  2. Klüter, T. et al., Electromagn Biol Med. 2018;37(4):175-183. doi: 10.1080/15368378.2018.1499030
  3. Klüter, T. et al., J Orthop Ther. 2018: JORT-1113. doi: 10.29011/2575-8241.001113
  4. Gerdesmeyer, L. et al., J Foot Ankle Surg. 2017;56(5):964-967. doi: 10.1053/j.jfas.2017.06.014